1UCD Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland. 2Systems Biology Ireland, UCD School of Medicine, University College Dublin, ...

Cancer Res (2023) 83 (7_Supplement): ND02.

Abstract. Effects of prolonging adjuvant aromatase inhibitor therapy beyond five years on recurrence and cause-specific mortality: an EBCTCG meta-analysis of individual patient data from 12 randomised ...

Cancer Res (2022) 82 (12_Supplement): 3595. Combination treatment with RMC-6291 and SHP2 or SOS1 inhibitors was well tolerated in preclinical models and further increased anti-tumor activity, likely ...

Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain. Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), ...

1Department of Oncology, University of Lausanne, Lausanne, Switzerland.

Divarasib plus cetuximab is well tolerated in patients with KRAS G12C-positive colorectal cancer.

1School of Medicine, University of California San Diego, La Jolla, California. *Corresponding Author: James T. Robinson, School of Medicine, University of California ...

1Whitehead Institute for Biomedical Research, Cambridge, Massachusetts. 2Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts. 3Ludwig MIT Center for Molecular ...

Cancer Res (2025) 85 (8_Supplement_1): 6376.

1Novelty Nobility, lnc., Seongnam-si, Republic of Korea.

1Lady Davis Institute for Medical Research, SMBD-Jewish General Hospital, McGill University, Montreal, Québec, Canada. 2Departments of Oncology and Medicine, Faculty ...